PMID,Title,Journal,Year
40555693,The effects of anti-obesity medications on bone metabolism: A critical appraisal.,"Diabetes, obesity & metabolism",2025
40129942,Semaglutide promotes the proliferation and osteogenic differentiation of bone-derived mesenchymal stem cells through activation of the Wnt/LRP5/beta-catenin signaling pathway.,Frontiers in pharmacology,2025
39366019,Semaglutide exposure and its association with adverse outcomes in diabetic patients undergoing transforaminal lumbar interbody fusion for lumbar degenerative disc disease.,Journal of neurosurgery. Spine,2025
39254876,The crucial role of beta-catenin in the osteoprotective effect of semaglutide in an ovariectomized rat model of osteoporosis.,Naunyn-Schmiedeberg's archives of pharmacology,2025
38864922,Glucagon-like Peptide-1 Receptor Agonists and Diabetic Osteopathy: Another Positive Effect of Incretines? A 12 Months Longitudinal Study.,Calcified tissue international,2024
38720191,Impact of GLP-1 Receptor Agonist Use in Patients With Steatotic Liver Disease and Type 2 Diabetes: A Retrospective Cohort Study.,Journal of pharmacy practice,2024
37999750,Narrative Review of Effects of Glucagon-Like Peptide-1 Receptor Agonists on Bone Health in People Living with Obesity.,Calcified tissue international,2024
35589613,Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications.,"Diabetes, obesity & metabolism",2022
31321014,Effects of glucagon-like peptide 1 receptor agonists on comorbidities in older patients with diabetes mellitus.,Therapeutic advances in chronic disease,2019
